Development of a minimally-invasive ultrasound guided rat myocardial infarction model to replace the gold standard invasive thoracotomy approach

NC3Rs · United Kingdom government procurement

Closed May 31, 2028. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

In the UK, 7.6 million people are living with heart and circulatory diseases which are subsequently responsible for 27% of deaths, with myocardial Infarction (MI) and heart failure a major factor (BHF Factsheet 2024). Rodent MI models using infarcts generated via invasive thoracotomy have been the cornerstone of cardiovascular research, allowing investigation of the pathological mechanisms driving adverse outcomes, identifying imaging/therapeutic targets and evaluating novel therapies. Rats are particularly important to preclinical molecular imaging studies using positron emission tomography (PET), owing to their larger size vs. mice and the resolution of preclinical PET scanners (~1mm).
In the last decade across the UK, 79 papers have been published using invasive rat MI models, representing the use of thousands of rats. This application aims to significantly reduce these numbers, and greatly refine these models which are classified as severe, through the development of a first-of-its-kind ultrasound guided minimally-invasive approach to MI generation in rats. This novel model, developed by embedding the 3Rs principals of reduction and refinement, will replace the gold standard approach of invasive infarct generation in rats and remove the need for: mechanical ventilation, skin incision, thoracotomy, lung collapse, pericardium rupture, exteriorisation of the heart, muscle/skin wound closure and breathing reflex recovery. Due to the exclusion of these aspects, we anticipate that our minimally-invasive model will result in a significantly higher recovery rate which will reduce the number of animals required, as well as reducing pain and suffering while shortening procedure and recovery times. Further to this, under ultrasound guidance, we propose that there will be greater control of infarct size, reducing the likelihood of unnecessarily large infarct sizes and missed occlusions. These expectations are based on an equivalent minimally-invasive model in mice using...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNC3Rs
CountryUnited Kingdom
CategoryResearch Development
PublishedMay 31, 2025
Procurement stageActive solicitation
ClosedMay 31, 2028
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Combining machine learning and human skin explant models to harness beneficial skin microbes to treat atopic dermatitis.
Investigation of dopamine transporter dysfunction linked to DAT/SLC6A3 mutations in CRISPR-Cas engineered C. elegans and patient derived iPSCs
Using a defined 3D human organoid model to replace the use of animals in the screening and evaluation of treatments for prostate cancer
RFI - Child Digital Health Services
Capital Programme Delivery Framework(s)
715863477 - Defence Hard Facilities Management (UK Estate)
Pharmaceutical Wholesale Services
Integrated Partnerships Framework

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.